Search

everythinglearnresearchcommunity

for

Search:↓

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

Treating hair loss in both men and women is effective and improves quality of life.

Male and female hair loss have different genetic causes.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

Fat-derived stem cells show promise for treating skin issues and improving wound healing, but more research is needed to confirm the best way to use them.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Laser treatment effectively increases hair density and thickness in androgenic alopecia.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

Both PRP and MZT treatments can significantly improve hair growth in patients with androgenetic alopecia.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

The microbiome may be linked to hair loss and could be a target for new treatments.

Hair length and thickness are related, with thickness peaking at about a quarter of the hair's maximum length.

As people get older, they have less active hair growth, but women have thicker hair than men and respond better to hair loss treatments.

Ostrich antibodies can help restore hair growth in people with a specific type of hair loss, increasing hair count by 71% on average.

A new method using fat tissue cells may help treat hair loss.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

The combined treatment increased hair density in most patients with Androgenetic Alopecia.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Trichoscopy and trichogram are useful for diagnosing hair and scalp conditions.

Hair transplant works well, but needs more research for better results.